Welcome to LookChem.com Sign In|Join Free

CAS

  • or

887572-60-3

Post Buying Request

887572-60-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

887572-60-3 Usage

General Description

5-Methoxy-1H-benzimidazole-2-carboxylic acid is a chemical compound with the molecular formula C10H9NO3. It is a derivative of the benzimidazole class of compounds and features a carboxylic acid group as well as a methoxy group attached to the benzene ring. 5-METHOXY-1H-BENZOIMIDAZOLE-2-CARBOXYLICACID has potential pharmaceutical applications and may be used in the development of drugs targeting various biological pathways. Its precise functions and applications are still being explored, but it has shown promise as a building block for the synthesis of new pharmaceutical agents. Additionally, it may have potential use in research and development activities related to medicinal chemistry and drug discovery.

Check Digit Verification of cas no

The CAS Registry Mumber 887572-60-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,5,7 and 2 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 887572-60:
(8*8)+(7*8)+(6*7)+(5*5)+(4*7)+(3*2)+(2*6)+(1*0)=233
233 % 10 = 3
So 887572-60-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H8N2O3/c1-14-5-2-3-6-7(4-5)11-8(10-6)9(12)13/h2-4H,1H3,(H,10,11)(H,12,13)

887572-60-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-methoxy-1H-benzimidazole-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names 5-methoxy-1H-benzimidazole-2-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:887572-60-3 SDS

887572-60-3Relevant articles and documents

Synthesis and evaluation of selected benzimidazole derivatives as potential antimicrobial agents

Alasmary, Fatmah A.S.,Snelling, Anna M.,Zain, Mohammed E.,Alafeefy, Ahmed M.,Awaad, Amani S.,Karodia, Nazira

, p. 15206 - 15223 (2015/09/21)

A library of 53 benzimidazole derivatives, with substituents at positions 1, 2 and 5, were synthesized and screened against a series of reference strains of bacteria and fungi of medical relevance. The SAR analyses of the most promising results showed that the antimicrobial activity of the compounds depended on the substituents attached to the bicyclic heterocycle. In particular, some compounds displayed antibacterial activity against two methicillin-resistant Staphylococcus aureus (MRSA) strains with minimum inhibitory concentrations (MICs) comparable to the widely-used drug ciprofloxacin. The compounds have some common features; three possess 5-halo substituents; two are derivatives of (S)-2-ethanaminebenzimidazole; and the others are derivatives of one 2-(chloromethyl)-1Hbenzo[ d]imidazole and (1H-benzo[d]imidazol-2-yl)methanethiol. The results from the antifungal screening were also very interesting: 23 compounds exhibited potent fungicidal activity against the selected fungal strains. They displayed equivalent or greater potency in their MIC values than amphotericin B. The 5-halobenzimidazole derivatives could be considered promising broad-spectrum antimicrobial candidates that deserve further study for potential therapeutic applications.

New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation

Frohn, Mike,Xu, Han,Zou, Xiaoming,Chang, Catherine,McElvaine, Michele,Plant, Matthew H.,Wong, Min,Tagari, Philip,Hungate, Randall,Buerli, Roland W.

, p. 6633 - 6637 (2008/03/18)

We report the development of the novel N-substituted benzimidazole 11 as a potent and selective human formyl peptide receptor-like 1 (hFPRL1) agonist. This compound and its less active enantiomer 12 were identified as useful tools for studying receptor function in vitro.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 887572-60-3